Patients with some gastrointestinal tumors were able to be treated with immunotherapy drugs alone and avoid surgery, ...

An immuno-based treatment targeting cancer cells with mismatch repair-deficiency could help those with the disease treat ...

The investigational oral tyrosine kinase inhibitor (TKI) zongertinib showed promise in patients with previously treated HER2 ...

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

New research shows 92% of cancer patients stayed cancer-free for two years after immune-based therapy, potentially avoiding ...

AACR president received a standing ovation in rousing call to action for the cancer research community's response to funding ...

Cancer survivors who reported feeling cancer-related fatigue or depression reduced their recreational activities nearly ...

From 2010 to 2020, breast cancer deaths among women ages 20–49 declined significantly across all breast cancer subtypes and ...

From 2010 to 2020, breast cancer deaths among women ages 20-49 declined significantly across all breast cancer subtypes and racial/ethnic groups, with marked declines starting after 2016, according to ...

A Stage 4 cancer survivor is grateful for a 'lifesaving' clinical trial, but experts are wary over potential federal funding ...